108 related articles for article (PubMed ID: 19142506)
1. [Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators].
Jobim FC; Schwartsmann G; Xavier NL; Uchoa Dde M; Saciloto M; Chemello N
Rev Bras Ginecol Obstet; 2008 Jun; 30(6):287-93. PubMed ID: 19142506
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
4. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Thammineni KL; Thakur GK; Kaur N; Banerjee BD
Mol Cell Biochem; 2019 Jul; 457(1-2):93-103. PubMed ID: 30993496
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
Scorilas A; Karameris A; Arnogiannaki N; Ardavanis A; Bassilopoulos P; Trangas T; Talieri M
Br J Cancer; 2001 Jun; 84(11):1488-96. PubMed ID: 11384099
[TBL] [Abstract][Full Text] [Related]
6. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
8. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
[TBL] [Abstract][Full Text] [Related]
9. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
Zheng SQ; Huang RQ; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
[TBL] [Abstract][Full Text] [Related]
13. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Int J Oncol; 2000 Dec; 17(6):1099-105. PubMed ID: 11078794
[TBL] [Abstract][Full Text] [Related]
14. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
16. Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Puzovic V; Brcic I; Ranogajec I; Jakic-Razumovic J
Neoplasma; 2014; 61(4):439-46. PubMed ID: 24645837
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
[TBL] [Abstract][Full Text] [Related]
18. Influence of VEGF, COX-2, and MMP-9 expression on the molybdenum-targeted X-ray in breast cancer.
Zhang Y; Dang S; Wan Y; Yang F; Li T
Eur J Gynaecol Oncol; 2017; 38(1):45-48. PubMed ID: 29767863
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Henriques AC; de Matos FR; Galvão HC; Freitas Rde A
J Oral Sci; 2012 Mar; 54(1):105-11. PubMed ID: 22466894
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
